ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
-0,01%
Bitcoin
104.977,97
0,12%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. CSE

  6. Kal Minerals Corp (KAL) Börsenkurse

Kal Minerals Corp

Kal Minerals Corp (KAL)

Kalgoorlie Gold Mining Ltd
0,14
0,00
(0,00%)
Geschlossen 25 Januar 10:00PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,14
Gebot
0,135
Fragen
0,40
Volumen
-
0,00 Tagesbereich 0,00
0,14 52-Wochen-Bereich 0,14
Handelsende
0,14
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

KAL Neueste Nachrichten

Weitere Nachrichten

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

20 September 2007
PR Newswire (US)

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

29 August 2007
PR Newswire (US)

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

11 August 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

09 August 2007
PR Newswire (US)

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

08 August 2007
PR Newswire (US)

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

07 August 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

25 Juni 2007
PR Newswire (US)

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

08 Juni 2007
PR Newswire (US)

Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, May 24 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drugs for the treatment of cancer and inflammatory diseases, announced today...

24 Mai 2007
PR Newswire (US)

Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal

History of Atiprimod Appears in Genetic Engineering & Biotechnology News NEW YORK, May 15 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical...

15 Mai 2007
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.140.140.1400CS
4000.140.140.1400CS
12000.140.140.1400CS
26000.140.140.1400CS
52000.140.140.1400CS
156000.140.140.1400CS
2600.06750.080.160.0816010.12165007CS

KAL - Frequently Asked Questions (FAQ)

What is the current Kal Minerals share price?
The current share price of Kal Minerals is $ 0,14
What is the 1 year trading range for Kal Minerals share price?
Kal Minerals has traded in the range of $ 0,14 to $ 0,14 during the past year

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MLKMMayo Lake Minerals Inc
$ 0,035
(133,33%)
13k
CATCAT Strategic Metals Corporation
$ 0,01
(100,00%)
2k
BHCCBlue Horizon Global Capital Corp
$ 0,01
(100,00%)
4k
IANiAnthus Capital Holdings Inc
$ 0,01
(100,00%)
85k
AWRAurwest Resources Corporation
$ 0,01
(100,00%)
3k
DDDouble Deuce Exploration Corp
$ 0,11
(-54,17%)
1,05k
AFXArctic Fox Lithium Corp
$ 0,005
(-50,00%)
38,33k
PNGCLoyalist Exploration Limited
$ 0,005
(-50,00%)
300k
TUGATuga Innovations Inc
$ 0,01
(-50,00%)
62k
SURESureNano Science Ltd
$ 0,08
(-44,83%)
34,5k
NFLDExploits Discovery Corp
$ 0,04
(0,00%)
3,51M
ONCOOnco Innovations Limited
$ 2,55
(15,91%)
3,05M
WHIPCredissential Inc
$ 0,105
(-19,23%)
2,73M
HVWHi View Resources Inc
$ 0,055
(-15,38%)
1,96M
BCBCBC Bud Corporation
$ 0,14
(0,00%)
1,53M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

CSE
KAL
Kal Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten